PRLD
Prelude TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The bull case is that PRLD has turned its strategic reset into visible execution: PRT12396 is in Phase 1, PRT13722 remains on track for a mid-2026 IND and 2H 2026 initiation, and cash now extends into Q2 2028 after the May financing [#SEC-8K-2026-05-12] [#10-K-2026-03-10]. That creates multiple shots on goal without a near-term financing spiral.
Posture
Constructive
Lead driver
Momentum
What changed
News driver: Insider Buying : Prelude Therapeutics ( NASDAQ : PRLD ) Director Acquires 2 , 815 , 315 Shares of Stock.
What can break
Coverage is thin; the post-print analyst revisions are informative but not yet a durable validation signal [#PR-EARNINGS-2026-05-16].
Momentum
85
Value
41
Sentiment
75
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $3.50 · Bull $6.25 · Bear $1.50
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $3.50
Why
Momentum85 · Δ7d -9.1
Value41 · Δ7d +0.1
Sentiment75 · Δ7d +15.8
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
85
34% active weight
Current posture
7d trendSoftening
Δ7d
-9.1
Δ21d
-10.3
Value
41
32% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
+0.2
Sentiment
75
33% active weight
Current posture
7d trendImproving
Δ7d
+15.8
Δ21d
+33.7
Why this grade
Composite grade A. Momentum 85.1 / Value 41.1 / Sentiment 75.3
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$304.25M
Beta
0.88
Shares Out
50.02M
P/E (TTM) · Derived
-3.6
P/S (TTM)
14.61
P/FCF (TTM) · Derived
-4.61
Rev YoY
+116.7%
EPS YoY
+39.1%
Gross Margin
-
Op Margin
-1152.8%
Net Debt
-$133.41M
Current Ratio
3.21
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology

